Insider Stock Trading History of Aunins John G.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Aunins John G. since year 2005. The trader's CIK number is 1643756. At the time of this reporting, Aunins John G. is the Chief Technology Officer & EVP of Seres Therapeutics, Inc. . (stock ticker symbol MCRB). See this page for all insider trading activities at Seres Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Aunins John G. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-07-15 MCRB Seres Therapeutics, Inc. Sale 14,279 8.11 115,731
2018-06-19 MCRB Seres Therapeutics, Inc. Option Ex 5,000 .00 0
2018-06-15 MCRB Seres Therapeutics, Inc. Sale 14,279 8.57 122,328
2018-04-25 MCRB Seres Therapeutics, Inc. Sale 14,279 7.58 108,263
2018-01-26 MCRB Seres Therapeutics, Inc. Option Ex 5,000 .00 0
2018-01-26 MCRB Seres Therapeutics, Inc. Sale 1,738 11.02 19,152
2017-12-19 MCRB Seres Therapeutics, Inc. Option Ex 5,000 .00 0
2017-12-19 MCRB Seres Therapeutics, Inc. Sale 1,623 10.14 16,457
2016-08-29 MCRB Seres Therapeutics, Inc. Sale 9,390 10.87 102,069
2016-07-27 MCRB Seres Therapeutics, Inc. Sale 9,250 35.00 323,750
2016-07-22 MCRB Seres Therapeutics, Inc. Option Ex 187,500 .48 90,000
2016-07-25 MCRB Seres Therapeutics, Inc. Sale 9,390 34.18 320,950
2016-06-27 MCRB Seres Therapeutics, Inc. Sale 9,390 27.23 255,689
2016-05-31 MCRB Seres Therapeutics, Inc. Sale 14,015 30.30 424,584
2016-04-25 MCRB Seres Therapeutics, Inc. Sale 18,640 31.94 595,361
2016-03-28 MCRB Seres Therapeutics, Inc. Sale 9,390 23.89 224,327

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aunins John G. (Chief Technology Officer & EVP of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.